Condition:   Rheumatoid Arthritis
Interventions:   Drug: tocilizumab [RoActemra/Actemra];   Drug: DMARDs
Sponsors:   Hoffmann-La Roche;   Hoffmann-La Roche
Recruiting - verified September 2013